Blauvelt A, Alonso-Llamazares J, Bhatia N, Draelos Z, DuBois J, Forman S, Gooderham M, Guenthner S, Hebert A, Lain E, Moore A, Papp K, Stein Gold L, Zirwas M, Kato S, Snyder S, Krupa D, Burnett P, Berk D, Chu D. Efficacy and Safety of Roflumilast Foam 0.3% in Patients With Seborrheic Dermatitis in a Phase 3 Trial. J of Skin [Internet]. 2023Mar.13 [cited 2025Jan.20];7(2):s196. Available from: https://skin.dermsquared.com/skin/article/view/2037